BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8589253)

  • 1. Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositol-3-OH kinase.
    Barchi JJ; Nomizu M; Otaka A; Roller PP; Burke TR
    Biopolymers; 1996 Feb; 38(2):191-208. PubMed ID: 8589253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding.
    Burke TR; Nomizu M; Otaka A; Smyth MS; Roller PP; Case RD; Wolf G; Shoelson SE
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1148-53. PubMed ID: 8024556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites.
    Günther UL; Liu Y; Sanford D; Bachovchin WW; Schaffhausen B
    Biochemistry; 1996 Dec; 35(48):15570-81. PubMed ID: 8952511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
    Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
    J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.
    Nolte RT; Eck MJ; Schlessinger J; Shoelson SE; Harrison SC
    Nat Struct Biol; 1996 Apr; 3(4):364-74. PubMed ID: 8599763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphopeptide binding to the N-terminal SH2 domain of the p85 alpha subunit of PI 3'-kinase: a heteronuclear NMR study.
    Hensmann M; Booker GW; Panayotou G; Boyd J; Linacre J; Waterfield M; Campbell ID
    Protein Sci; 1994 Jul; 3(7):1020-30. PubMed ID: 7522724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.
    Breeze AL; Kara BV; Barratt DG; Anderson M; Smith JC; Luke RW; Best JR; Cartlidge SA
    EMBO J; 1996 Jul; 15(14):3579-89. PubMed ID: 8670861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
    Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
    J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of calcium-dependent conformational changes in the N-terminal SH2 domains of p85 and GAP defines distinct properties for SH2 domains.
    Mahadevan D; Thanki N; McPhie P; Beeler JF; Yu JC; Wlodawer A; Heidaran MA
    Biochemistry; 1994 Jan; 33(3):746-54. PubMed ID: 8292602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
    Long YQ; Lung FD; Roller PP
    Bioorg Med Chem; 2003 Sep; 11(18):3929-36. PubMed ID: 12927853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activity.
    Eaton SR; Cody WL; Doherty AM; Holland DR; Panek RL; Lu GH; Dahring TK; Rose DR
    J Med Chem; 1998 Oct; 41(22):4329-42. PubMed ID: 9784108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
    Pletneva EV; Laederach AT; Fulton DB; Kostic NM
    J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
    Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
    Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.